Procoagulant properties of human MV3 melanoma cells

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 2, 2008, Pages 99-105

  Geaquinto, D L A ^a   Fernandes, R S ^a   Lima, L G ^a   Barja Fidalgo, C ^b   Monteiro, Robson Q ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Blood clotting; MV3 melanoma; Thrombin; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING INITIATOR PROTEIN; DEXTRO PHENYLALANYLPIPECOLYLARGININE 4 NITROANILIDE; FIBRINOGEN; MONOCLONAL ANTIBODY; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CANCER CELL CULTURE; CELL ACTIVITY; CELL ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MELANOMA CELL; MOLECULAR DYNAMICS; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN PROTEIN INTERACTION;

BOVINAE;

EID: 41149179003     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008005000003     Document Type: Article

References (37)

1. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165-174.
2. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-1022.
3. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-1389.
4. Mandala M, Ferretti G, Cremonesi M, Cazzaniga M, Curigliano G, Barni S. Venous thromboembolism and cancer: new issues for an old topic. Crit Rev Oncol Hematol 2003; 48: 65-80.
5. Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res 2001; 102: V187-V194.
6. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001; 102: V215-V224.
7. Connor J, Bucana C, Fidler IJ, Schroit AJ, Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaf-let lipid by prothrombinase complex formation. Proc Natl Acad Sci U S A 1989; 86: 3184-3188.
8. Barrowcliffe TW, Fabregas P, Jardi M, Cancelas J, Rabaneda M, Felez J. Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid. Thromb Haemost 2002; 87: 442-449.
9. VanDeWater L, Tracy PB, Aronson D, Mann KG, Dvorak HF. Tumorcell generation of thrombin via functional pro-thrombinase assembly. Cancer Res 1985; 45: 5521-5525.
10. Kirszberg C, Rumjanek VM, Monteiro RQ. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells. Thromb Res 2005; 115:123-129.
11. Fernandes RS, Kirszberg C, Rumjanek VM, Monteiro RQ. On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells. J Thromb Haemost 2006; 4: 1546-1552.
12. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3: 379-384.
13. Guan M, Jin J, Su B,,Liu WW, Lu Y. Tissue factor expression and angiogenesis in human glioma. Clin Biochem 2002; 35: 321-325.
14. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002; 69: 247-254.
15. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998; 4: 909-914.
16. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulafion pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 2005; 25: 1545-1550.
17. Rao LV, Pendurthi UR. Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol 2005; 25: 47-56.
18. Mueller BM, Reisfeld RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A 1992; 89: 11832-11836.
19. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A 1995; 92: 8205-8209.
20. van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, Ruiter DJ. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 1991; 48: 85-91.
21. Bezeaud A, Denninger MH, Guillin MC. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem 1985; 153: 491-496.
22. Francischetti IM, Valenzuela JG, Ribeiro JM. Anophelin: kinetics and mechanism of thrombin inhibition. Biochemistry 1999; 38: 16678-16685.
23. Amirkhosravi A, Biggerstaff JP, Warnes G, Francis DA, Francis JL. Determination of tumor cell procoagulant activity by Sonoclot analysis in whole blood. Thromb Res 1996; 84: 323-332.
24. Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, et al. Regulabon of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A 1999; 96: 8663-8668.
25. Sakai T, Noguchi M, Kisiel W. Tumor cells augment the factor Xa-catalyzed conversion of prothrombin to thrombin. Haemostasis 1990; 20: 125-135.
26. Kumar A, Koenig KB, Johnson AR, Idell S. Expression and assembly of procoagulant complexes by human pleural mesothelial cells. Thromb Haemost 1994; 71: 587-592.
27. Kumar A, Koenig KB, Johnson AR, Fair DS, Idell S. Inhibition of factor Xa-mediated procoagulant activity of human lung fibroblasts and pleural mesothelial cells. Eur Respir J 1995; 8: 2038-2045.
28. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991; 87: 229-236.
29. Wojtukiewicz MZ, Tang DG, Ciarelli JJ Nelson KK, Walz DA, Diglio CA, et al. Thrombin increases the metastatic potential of tumor cells. Int J Cancer 1993; 54: 793-806.
30. Esumi N, Fan D, Fidler IJ. Inhibition murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res 1991; 51: 4547-4556.
31. Hu L, Lee M, Campbell W, Perez-Soler R, Karpatkin S. Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. Blood 2004; 104: 2746-2751.
32. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony fomation. Cancer Res 2004; 64: 8613-8619.
33. Nierodzik ML, Chen K, Takeshita K, Li JJ, Huang YQ, Feng XS, et al. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 1998; 92: 3694-3700.
34. Tellez C, Bar-Eli M. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 2003; 22: 3130-3137.
35. Shi X, Gangadharan B, Brass LF, Ruf-W, Mueller BM. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2004; 2: 395-402.
36. Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak AM, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989; 948: 305-326.
37. Fernandez PM, Patierno SR, Rickles FR. Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost 2004; 30: 31-44.